Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • Herrstedt, Jørn
  • Wichit Apornwirat
  • Ahmed Shaharyar
  • Zeba Aziz
  • Fausto Roila
  • Simon Van Belle
  • Mark W Russo
  • Jeremey Levin
  • Salabha Ranganathan
  • Mary Guckert
  • Steven M Grunberg
Udgivelsesdato: 2009-Nov
OriginalsprogEngelsk
TidsskriftJournal of Clinical Oncology
Vol/bind27
Udgave nummer32
Sider (fra-til)5363-9
Antal sider7
ISSN0732-183X
DOI
StatusUdgivet - 2009

ID: 20572186